WallStSmart
NPCE

Neuropace Inc

NASDAQ: NPCE · HEALTHCARE · MEDICAL DEVICES

$15.67
+2.77% today

Updated 2026-06-04

Market cap
$536.64M
P/E ratio
P/S ratio
5.39x
EPS (TTM)
$-0.65
Dividend yield
52W range
$8 – $20
Volume
0.2M

Neuropace Inc (NPCE) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2019202020212022202320242025
Revenue$36.97M$41.14M$45.18M$45.52M$65.42M$79.91M$99.99M
Revenue growth (YoY)+11.3%+9.8%+0.7%+43.7%+22.1%+25.1%
Cost of revenue$10.51M$10.87M$11.75M$13.03M$17.30M$20.82M$22.77M
Gross profit$26.46M$30.27M$33.44M$32.49M$48.12M$59.09M$77.22M
Gross margin71.6%73.6%74.0%71.4%73.6%73.9%77.2%
R&D$18.29M$15.70M$18.21M$21.95M$20.78M$23.65M$27.89M
SG&A$30.20M$27.63M$38.96M$51.34M$54.52M$17.43M$19.09M
Operating income$-22.03M$-13.05M$-23.74M$-40.79M$-27.17M$-21.67M$-16.34M
Operating margin-59.6%-31.7%-52.5%-89.6%-41.5%-27.1%-16.3%
EBITDA$-20.07M$-12.48M$-28.37M$-36.57M$-22.83M$-16.57M$-14.39M
EBITDA margin-54.3%-30.3%-62.8%-80.3%-34.9%-20.7%-14.4%
EBIT$-20.49M$-12.79M$-28.67M$-39.55M$-24.44M$-18.34M$-16.34M
Interest expense$9.48M$11.49M$7.41M$7.53M$8.52M$8.80M$7.46M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-29.97M$-24.28M$-36.08M$-47.08M$-32.96M$-27.14M$-21.46M
Net income growth (YoY)+19.0%-48.6%-30.5%+30.0%+17.6%+20.9%
Profit margin-81.1%-59.0%-79.9%-103.4%-50.4%-34.0%-21.5%

Frequently asked questions

What is Neuropace Inc's revenue?

Neuropace Inc's trailing twelve-month revenue is $99.53M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is NPCE?

In its most recent fiscal year, NPCE ran a gross margin of 77.23%, an operating margin of -16.34%, and a net margin of -21.47%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does NPCE generate?

NPCE produced $-11.34M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is NPCE's balance sheet healthy?

NPCE holds $21.69M in cash and equivalents against $58.88M in long-term debt, on $19.03M of shareholder equity. That debt is best read against the cash flow the business throws off each year.